Research map: Crinecerfont: emerging role in the management of congenital adrenal hyperplasia

Back to the article

Papers in this map

  1. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline · Phyllis Speiser · 2018 · 1224 citations · Cited by this paper
  2. The relationship between iron deficiency and thyroid function: findings from a population-based study in Jordan · 2026 · Related
  3. Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management · Hedi L. Claahsen‐van der Grinten · 2021 · 551 citations · Cited by this paper
  4. Exploring actions of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond glucose and obesity control: bone health and osteoporosis · 2026 · Related
  5. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency · Deborah P. Merke · 2020 · 339 citations · Cited by this paper
  6. The effects of levothyroxine monotherapy versus combination therapy on quality of life and patient satisfaction · 2025 · Related
  7. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study · Sebastian Brusell Gidlöf · 2013 · 186 citations · Cited by this paper
  8. Possible attenuation of gout risk by SGLT-2 inhibitors in patients using thiazide and loop diuretics · 2025 · Related
  9. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency · Anna Nordenström · 2018 · 160 citations · Cited by this paper
  10. The intersection of education and health: schools as a catalyst for childhood obesity prevention · 2026 · Related
  11. Biochemical and genetic diagnosis of 21-hydroxylase deficiency · Henrik Falhammar · 2015 · 80 citations · Cited by this paper
  12. Plasma vitamin D status and its association with biochemical, clinical and humanistic outcomes in diabetic foot infection patients: a prospective observational study in a tertiary healthcare facility · 2025 · Related
  13. Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia · Richard Joseph Auchus · 2024 · 65 citations · Cited by this paper
  14. Moving away from BMI: a new era of diagnostic criteria in obesity · 2025 · Related
  15. Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis · Diana MacKay · 2018 · 59 citations · Cited by this paper
  16. Metabolic aspects of polycystic ovary syndrome · 2026 · Related
  17. Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis · Swetha Rangaswamaiah · 2020 · 59 citations · Cited by this paper
  18. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia · Kyriakie Sarafoglou · 2024 · 56 citations · Cited by this paper
  19. Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency · Alina Oprea · 2019 · 54 citations · Cited by this paper
  20. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia · Richard Joseph Auchus · 2021 · 54 citations · Cited by this paper
  21. Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia · Alessandro Prete · 2021 · 50 citations · Cited by this paper
  22. Long‐term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia · Ashwini Mallappa · 2018 · 45 citations · Cited by this paper
  23. Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia: Results from Two Phase 2 Studies · Kyriakie Sarafoglou · 2021 · 45 citations · Cited by this paper
  24. Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study · Henrik Falhammar · 2021 · 41 citations · Cited by this paper
  25. Long-Term Outcomes of Congenital Adrenal Hyperplasia · Anna Nordenström · 2022 · 40 citations · Cited by this paper
  26. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia · Ron S. Newfield · 2023 · 35 citations · Cited by this paper
  27. Current and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia · Anna Nordenström · 2022 · 33 citations · Cited by this paper
  28. Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management · Kyriakie Sarafoglou · 2023 · 31 citations · Cited by this paper
  29. Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision) · Tomohiro Ishii · 2022 · 27 citations · Cited by this paper
  30. Ethnic and National Differences in Congenital Adrenal Hyperplasia Incidence: A Systematic Review and Meta-Analysis · Andrea N. Navarro-Zambrana · 2022 · 26 citations · Cited by this paper
  31. Cardiometabolic Aspects of Congenital Adrenal Hyperplasia · Robert G. Krysiak · 2024 · 22 citations · Cited by this paper
  32. Generation of glucocorticoid-producing cells derived from human pluripotent stem cells · Gerard Ruiz‐Babot · 2023 · 16 citations · Cited by this paper
  33. Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency · Kyriakie Sarafoglou · 2024 · 15 citations · Cited by this paper
  34. Patients with Hypocortisolism Treated with Continuous Subcutaneous Hydrocortisone Infusion (CSHI): An Option for Poorly Controlled Patients · Malene Lyder Mortensen · 2023 · 11 citations · Cited by this paper
  35. Genetics in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency and Clinical Implications · Paola Concolino · 2025 · 11 citations · Cited by this paper
  36. Recent advances in treatments for congenital adrenal hyperplasia · Henrik Falhammar · 2025 · 8 citations · Cited by this paper
  37. OR12-2 Inhibition of Basal and ACTH-stimulated Cortisol Secretion in Humans Using an Oral Nonpeptide ACTH Antagonist (CRN04894) · Stephen F. Betz · 2022 · 5 citations · Cited by this paper
  38. CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance · Patricio H. Contreras · 2025 · 4 citations · Cited by this paper
  39. The Current Treatment Landscape for Congenital Adrenal Hyperplasia · Joseph J. Tonge · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)